Sandoz (Generics)
Delivering affordable, high-quality medicines
Sandoz, the generic pharmaceuticals division of Novartis, is a global industry leader, offering affordable, high-quality medicines to everyone, everywhere. It is the second-largest division of Novartis.
2009 net sales - USD 7.5 billion
Sandoz develops and produces approximately 1 000 compounds, as well as active substances and intermediates. Our operations span five continents, and we market products in more than 130 countries.
In addition to its retail generics business, Sandoz operates three businesses that focus on anti-infectives, oncology injectables and biopharmaceuticals.
Key marketed products (retail generics):
| Product | Originator* | Drug Description |
|---|---|---|
| Omeprazole | Prilosec® (Procter & Gamble) | Ulcer and heartburn treatment |
| Amoxicillin / clavulanic acid | Augmentin® (GlaxoSmithKline) | Anti-infective |
| Metoprolol | Lopressor | Antihypertensive |
| Fentanyl | Duragesic® (Ortho-McNeil-Janssen Pharmaceuticals) | Analgesic |
| Amlodipine / Benazepril | Lotrel | Antihypertensive |
| Simvastatin | Zocor® (Merck & Co) | Cholesterol-lowering treatment |
| Acetylsteine | Fluimucil® (Zambon) | Respiratory disease therapy |
| Amlodipine | Norvasc® (Pfizer) | Hypertension |
| Tacrolimus | Prograf® (Astellas) | Transplantation |
| Amoxicillin | Amoxil® (GlaxoSmithKline) | Anti-infective |
*Product names identified by a “®” are trademarks that are not owned by or licensed to the Novartis Group of companies.
Company history
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz.
